Leveraging Population Health Analytics for Value-Based Care

Executive Summary

Value-based care (VBC) models require healthcare organizations to manage risk, utilization, and quality across defined populations rather than on an individual basis. Population health analytics enables this shift by providing population-level insights for risk adjustment, care gap closure, and performance monitoring. Traditional approaches, however, are often retrospective and limited by reliance on structured data, constraining their effectiveness under shared-risk and capitated arrangements.

Generative AI (Gen AI) strengthens population health analytics by improving the use of unstructured clinical data, enabling forward-looking analysis, and reducing administrative effort tied to value-based programs. From Avasant’s perspective,[1]^,[2] impact is driven less by model sophistication and more by disciplined execution, which involves the use of reliable data, contract-aligned use cases, and strong governance, and the integration into clinical and operational workflows. This approach enables organizations to manage risk and sustain performance under value-based care.

Analytics‑Led Transformation of Value‑Based Care Models

Value-based care models, such as ACOs and bundled payments, require population-level insights for accurate risk adjustment, care gap closure, and cost control. Traditional rule-based analytics, heavily dependent on structured claims and EHR data, are insufficient for these demands. Gen AI extends population health analytics by interpreting unstructured clinical and contextual data, enabling more timely decision-making across value-based programs.

Key ways Gen AI enables value-based care:

• • Expanded data usability: Transformer-based NLP models extract clinically relevant signals from physician notes, discharge summaries, imaging reports, and care management documentation, improving risk stratification and quality measurement beyond structured data alone.
  • Proactive population management: By combining predictive modeling with generative reasoning, Gen AI forecasts deterioration, utilization spikes, and quality measure gaps, supporting earlier, targeted interventions aligned with value-based contracts.
  • Reduced administrative burden: Gen AI automates quality reporting, evidence extraction, and measure interpretation, allowing care teams to focus on intervention rather than compliance.
  • Improved resource allocation: Population-level forecasting helps payors and providers deploy care management resources more efficiently across networks, supporting outcome improvement and cost containment.

How Gen AI Works on Population Health Data to Drive Value

Gen AI enhances population health analytics through a set of complementary capabilities that align directly with value-based care requirements for risk management, quality performance, and cost control. Rather than replacing traditional analytics, Gen AI augments them by synthesizing signals across heterogeneous data sources and translating predictions into insights.

Key functional contributions include the following:

• • Population risk stratification and segmentation: Gen AI models ingest multimodal data—clinical records, utilization history, and social determinants—to identify high-risk cohorts such as patients with escalating utilization, poorly controlled chronic conditions, or unmet social needs. Unlike static rule-based approaches, Gen AI continuously refines cohort definitions as new data becomes available, improving attribution accuracy and targeting under shared savings and capitated contracts.
  • Care gap identification and quality measure alignment: By interpreting unstructured clinical notes, care plans, and documentation, Gen AI can detect missing screenings, delayed follow-ups, or deviations from evidence-based pathways. These insights are directly mapped to value-based quality measures, allowing care teams to address gaps proactively rather than after the close of performance periods.
  • Predictive intervention planning: Gen AI synthesizes predictive model outputs into scenario-based recommendations, such as identifying which subpopulations would benefit most from care management outreach or estimating the impact of preventive interventions on population-level cost and outcomes. This supports more deliberate allocation of clinical and care management resources.
  • Performance monitoring and reporting: Continuous monitoring of utilization, cost, and quality metrics is central to value-based care. Gen AI automates the summarization of performance trends, highlights outliers, and surfaces emerging risks, enabling accountable care organizations and provider networks to course-correct more quickly.

Technology Foundation for the Analytics Framework

A Gen AI-enabled population health analytics framework for value-based care is built on modular, interoperable components that support large-scale data integration, advanced inference, and regulatory compliance. The objective is to enable longitudinal, population-level insight while maintaining clinical trust, data integrity, and privacy.

Key technology components include the following:

• • Gen AI and model layer: Large language models (LLMs), such as GPT-class models fine-tuned on healthcare corpora, provide generative reasoning, summarization, and simulation capabilities. These models are augmented with retrieval-augmented generation (RAG) using vector databases to ground outputs in authoritative clinical, operational, and contractual data.
  • Data ingestion and standardization: Interoperability standards such as FHIR and HL7 support ingestion from EHRs, claims systems, registries, and care management platforms. Common data models, including OMOP, enable normalization across sources and support multimodal analytics spanning clinical, financial, and social determinants data.
  • Data unification and entity resolution: Cloud-based data platforms and data mesh architectures resolve silos across payor and provider systems. Advanced identity resolution techniques achieve high patient matching accuracy, enabling reliable longitudinal population views required for risk adjustment and performance measurement.
  • Analytics and population scoring: Multimodal analytics pipelines combine structured data with unstructured embeddings to generate holistic population risk scores, incorporating social and behavioral factors alongside clinical indicators.
  • Security, privacy, and governance: Federated learning, differential privacy, and role-based access controls ensure compliance with HIPAA, GDPR, and regional data protection requirements. These controls also support edge and hybrid deployments where data residency or latency constraints apply.

Component	Function	Standards/Tools
Data ingestion	Unify EHRs, claims, and SDOH	FHIR, HL7, and OMOP ​
Embedding layer	Vectorize unstructured text/images	BioBERT and CLIP
Generation engine	Prompt-based synthesis	Llama-3 fine-tuned and RAG ​
Output governance	Bias checks and audit trails	SHAP explainability ​

Real-Life Implementations

The following examples illustrate how healthcare organizations and health service administrators are applying Gen AI and advanced analytics to population health use cases that directly support value-based care objectives. These implementations focus on operational decision support, risk stratification, care gap closure, and performance optimization at scale.

Implementation/Setting	Population health/VBC use case	Measured outcomes
Mayo Clinic – AI readmission model[3]	AI-based prediction of 30-day readmissions	• Model accuracy: 79% • A 16-percentage point improvement over LACE+ clinical reference standard • Lower false positives: 40% versus 62% for LACE+
Allina Health – Predictive analytics[4]	Predictive risk scoring for readmission reduction	• A 10.3% reduction in 30-day readmissions • Annual savings in avoided costs of $4.2M
Kaiser Permanente – Predictive deployment[5]	System-wide predictive risk modeling, including SDOH	• A 12% reduction in readmissions • Model accuracy improved from 68% to 84% after adding social determinants
Geisinger Health System – ProvenHealth Navigator[6]	VBC-aligned care coordination and population health	• A 7.9% reduction in total medical costs • An 18% reduction in hospital admissions
Blue Cross Blue Shield of Massachusetts – Alternative Quality Contract (AQC)[7]	Population-based payment model with performance incentives	• A 10% lower medical spending growth versus controls
Advocate Health Care + Blue Cross Blue Shield of Illinois – Accountable care organization (ACO)[8]	Shared savings ACO model	• Savings of $61M over four years • A 20% reduction in hospital admissions

 Implementing Value-Based Care with Population Health Analytics

The guidance below reflects Avasant’s viewpoint[9]^,[10] on how healthcare payors and providers can pragmatically implement value-based care using population health analytics and Gen AI. It emphasizes execution discipline, governance, and measurable outcomes over technology-led experimentation.

1. Implementation Road Map

Avasant recommends a phased approach that aligns analytics maturity with financial risk exposure under value-based arrangements.

Phase 1: Foundation and readiness (0–6 months)

• • • Define value-based objectives: Align population health use cases to contract structures (for instance, shared savings, bundles, and capitation) and priority outcomes such as readmissions, chronic disease control, or STAR/HEDIS performance.
    • Data readiness assessment: Evaluate completeness, timeliness, and consistency of clinical, claims, pharmacy, and social determinants data. Identify gaps that would limit risk adjustment or quality measurement.
    • Interoperability enablement: Establish ingestion pipelines using standards such as FHIR and HL7 to support longitudinal population views across payor and provider systems.
    • Governance and compliance setup: Define data ownership, model accountability, and review processes in anticipation of regulatory scrutiny for AI-enabled decision support.

Phase 2: Core population health analytics (6–12 months)

• • • Risk stratification and attribution: Deploy predictive and Gen AI-augmented models to segment populations by utilization risk, disease burden, and unmet social needs.
    • Care gap identification: Integrate analytics into care management and quality workflows to identify gaps tied directly to value-based measures.
    • Gen AI augmentation: Introduce NLP and retrieval-augmented generation (RAG) to incorporate unstructured clinical documentation into population insights.
    • Operational alignment: Embed insights into existing care management, utilization management, and quality reporting workflows rather than creating parallel systems.

Phase 3: Scale and optimization (12–24 months)

• • • Predictive intervention planning: Use Gen AI-enabled scenario modeling to prioritize interventions and simulate impact on cost and outcomes.
    • Performance monitoring: Automate population-level performance summaries and variance analysis to support continuous course correction.
    • Scalable architecture: Expand to hybrid or multicloud environments to support additional lines of business, geographies, and data modalities.
    • Financial optimization: Tie analytics outputs directly to contract performance management and shared savings calculations.

Avasant observes that organizations with mature VBC contracts typically realize measurable ROI within 12–18 months once analytics are operationalized.

2. Best Practices

Based on observed implementations, Avasant highlights the following practices as critical to success:

• • • Start with contract-driven use cases: Analytics should be anchored to specific value-based measures and risk corridors, not generic dashboards.
    • Blend structured and unstructured data early: Incorporating clinical notes and care management documentation materially improves risk and gap detection.
    • Use Gen AI as augmentation, not replacement: Pair generative models with deterministic rules and predictive analytics for reliability and auditability.
    • Design for explainability: Clinicians, auditors, and regulators must be able to understand how population-level insights are generated.
    • Invest in change management: Adoption depends as much on workflow redesign and clinician trust as on model performance.

3. Key Challenges and Mitigation Strategies

 

Challenge	Impact on VBC programs	Mitigation strategy
Data quality and bias	Inaccurate risk stratification and inequitable interventions	Implement data provenance tracking, enable continuous data quality monitoring, and use diverse, representative training datasets to reduce bias amplification
Model hallucinations	Risk of incorrect recommendations or summaries	Ground Gen AI outputs using retrieval-augmented generation (RAG) and enforce human-in-the-loop validation for high-impact decisions
Regulatory uncertainty	Delays or restrictions on AI-enabled decision support	Classify use cases by risk; apply FDA AI/ML guidance and conduct premarket review for high-risk clinical or utilization decisions
Scalability and cost control	Limited ability to expand across populations or contracts	Adopt hybrid cloud architectures that balance performance, data residency, and cost efficiency
Operational adoption	Insights fail to translate into action	Embed analytics directly into care, quality, and utilization workflows with clear ownership and accountability

 

4. Regulatory and Compliance Considerations

Value-based population health analytics increasingly intersect with evolving AI regulation. High-risk AI use cases, such as those that influence clinical decisions or coverage determinations, may fall under the FDA’s AI/ML-based software-as-a-medical-device (SaMD) framework. Avasant advises early regulatory assessment, documented model validation, and audit-ready governance structures to avoid downstream compliance issues.

Conclusion

Population health analytics enables value-based care at scale by assessing risks, targeting interventions, and tracking outcomes across populations. Gen AI enhances this by interpreting unstructured data, enabling predictive analysis, and supporting scenario planning for proactive care and resource decisions. Mature data platforms and workflow-embedded analytics shift organizations from retrospective reporting to proactive management, improving quality and financial predictability under shared-risk models.

From Avasant’s perspective, the effective use of population health analytics with Gen AI is primarily an execution challenge rather than a technology one. Sustainable impact depends on reliable data, clearly defined value-based use cases, appropriate governance of AI outputs, and close alignment with operational processes. Organizations that treat this as an incremental, managed transformation are better positioned to manage risk and achieve consistent performance under value-based care models.

References

[1] https://avasant.com/report/healthcare-payor-digital-services-2025-market-insights/

[2] https://avasant.com/report/healthcare-provider-digital-services-2025-market-insights/

[3] https://www.ache.org/-/media/ache/learning-center/research/2024-poster-presentation-posters/poster-16.pdf?

[4] https://sranalytics.io/blog/predictive-analytics-healthcare/

[5] https://sranalytics.io/blog/predictive-analytics-healthcare/

[6] https://medwave.io/2024/09/value-based-care-transforming-healthcare-delivery-and-outcomes/

[7] https://medwave.io/2024/09/value-based-care-transforming-healthcare-delivery-and-outcomes/

[8] https://medwave.io/2024/09/value-based-care-transforming-healthcare-delivery-and-outcomes/

[9] https://avasant.com/report/healthcare-payor-digital-services-2025-radarview/

[10] https://avasant.com/report/healthcare-provider-digital-services-2025-radarview/

Abbreviations

ACO – Accountable care organization

AI – Artificial intelligence

CLIP – Contrastive Language-Image Pretraining

EHR – Electronic health record

FDA – Food and Drug Administration

FHIR – Fast Healthcare Interoperability Resources

Gen AI – Generative artificial intelligence

GDPR – General Data Protection Regulation

GPT – Generative pretrained transformer

HEDIS – Healthcare Effectiveness Data and Information Set

HIPAA – Health Insurance Portability and Accountability Act

HL7 – Health Level Seven

LACE – Length of stay, Acuity of admission, Comorbidities, Emergency department visits

LLM – Large language model

NLP – Natural language processing

OMOP – Observational Medical Outcomes Partnership

RAG – Retrieval‑augmented generation

SaMD – Software as a medical device

SDOH – Social determinants of health

SHAP – SHapley Additive exPlanations

STAR – CMS Star Ratings

VBC – Value-based care

---

By Eratha Poongkuntran, Associate Director